ArticleHealth science reports2025
Global Burden of Colorectal Cancer in Adolescents and Young Adults From 1990 to 2021: A Systematic Analysis of the Global Burden of Disease Study 2021.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Global burden of early-onset colorectal cancer related to alcohol, tobacco, and physical inactivity: evidence from the global burden of disease 2021.Frontiers in oncology · 2026Article
- Global Burden of Colorectal Cancer in Adolescents and Young Adults From 1990 to 2021: A Systematic Analysis of the Global Burden of Disease Study 2021.Health science reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Colorectal cancer (CRC) is a major global health concern, with rising early-onset cases (EOCRC) among adolescents and young adults (AYAs, 15-39 years). This study evaluates the global burden, trends, and risk factors of AYA CRC from 1990 to 2021 using Global Burden of Disease (GBD) 2021 data. Methods: Utilizing GBD 2021 estimates, we analyzed incidence, prevalence, mortality, disability-adjusted life years (DALYs), and attributable risk factors. To analyze temporal trends, we employed joinpoint regression with a maximum of four nodes, and future burden projections were generated using ARIMA models. Analyses were stratified by age, sex, region, and Socio-Demographic Index (SDI). Results: Global AYA CRC incidence rose from 41,384 cases in 1990 to 70,201 in 2021 (AAPC: 0.35), with the highest age-standardized incidence rate (ASIR) in East Asia (5.11 per 100,000). Mortality decreased (AAPC: -1.00), driven by improved healthcare, while prevalence increased. Low whole-grain intake (15.9% DALYs) and high red meat consumption (12.7%) dominated globally, while high BMI emerged as a growing contributor, particularly in high-SDI regions. Males had higher burden than females, peaking at ages 35-39. By 2060, the ASIR is projected to rise by 14.7%, with the most pronounced increases in low-middle SDI regions, where healthcare infrastructure remains underdeveloped. Conclusion: The rising incidence of AYA CRC underscores urgent needs for targeted prevention, early screening, and lifestyle interventions addressing modifiable risks like diet and obesity. Geographic and socioeconomic disparities highlight the importance of equitable healthcare access to mitigate future burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.